Micronized Carbohydrates Improve Flowability in Powdered Infant Formula
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Powdered infant formulas with large lipid globules face challenges in flowability and cohesiveness, leading to caking and nutrient imbalance issues during manufacturing and consumer handling, while traditional free-flowing agents like silica are not approved for infant formula nutrients.
Innovation Solution
The use of micronized carbohydrates such as lactose, glucose, maltodextrin, starch, and inulin improves the flowability and reduces cohesiveness of powdered nutritional compositions by distributing fine carbohydrate particles alongside larger lipid globules, ensuring compliance with regulatory standards.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If large lipid globules are used in powdered nutritional compositions, then health benefits and similarity to human milk are improved, but flowability and handling properties deteriorate
Solution Approach 1:
The patent introduces a flowing agent as an intermediary substance to mediate between the large lipid globules and the powder matrix. This flowing agent reduces cohesion between particles, enabling the powder to flow properly while maintaining the beneficial large lipid globule structure. The flowing agent acts as a bridge that prevents direct contact and adhesion between lipid globule-containing particles.
Solution Approach 2:
The patent modifies the physical-chemical parameters of the powder system by introducing a flowing agent that changes the surface properties and interparticle forces. This parameter change allows the powder to achieve adequate flowability without altering the fundamental structure and size of the lipid globules, thus maintaining health benefits while improving handling.
2Stability of the object's composition
If large lipid globules are used in powdered nutritional compositions, then similarity to human milk is improved, but cohesiveness and caking increase
Solution Approach 1:
The flowing agent serves as a protective intermediary layer between particles containing large lipid globules. This layer prevents direct contact that would lead to caking and cohesion, while allowing the lipid globules to maintain their natural size and composition, preserving similarity to human milk.
Solution Approach 2:
The patent extracts the problematic cohesive properties from the system by introducing a flowing agent that separates and isolates the lipid globule-containing particles. This extraction of cohesion problems allows the beneficial composition similar to human milk to be maintained without the harmful caking effect.
3Ease of operation
If traditional free-flowing agents like silica are used, then flowability is improved, but regulatory compliance deteriorates
Solution Approach 1:
The patent replaces permanent, non-compliant free-flowing agents like silica with a compliant flowing agent that can be used in infant formula. The flowing agent is selected from substances approved by regulatory bodies, ensuring compliance while maintaining the desired flowability properties throughout the product shelf life.
Solution Approach 2:
The patent changes the chemical composition parameters of the free-flowing agent from non-compliant materials (silica) to compliant materials approved for infant formula. This parameter change maintains the functional property of improving flowability while satisfying regulatory requirements for nutritional safety.
Data Source
AI summary
The invention pertains to powdered nutritional compositions comprising large lipid globules and micronized carbohydrate or carbohydrate microcrystals. Preferably the nutritional composition is an infant or follow on formula or a growing up milk. The invention also pertains to the use of micronized carbohydrate or carbohydrate microcrystals for improving flow and reducing cohesiveness of a powdered nutritional composition with large lipid globules.